Wordt geladen...
The role of ofatumumab in the treatment of chronic lymphocytic leukemia resistant to previous therapies
Chronic lymphocytic leukemia (CLL) is an indolent but incurable disease. Despite the improvement of the available therapies, the management of heavily-treated CLL patients represents a challenge for modern practitioners. Ofatumumab is a second-generation, fully human anti-CD20 monoclonal antibody th...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2010
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3262337/ https://ncbi.nlm.nih.gov/pubmed/22282677 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|